April 27, 2023 2:08 am
Facebook will be launching an Israeli satellite to help billions of people in the sub-Saharan Africa to access Internet. This will be a part of Internet.org initiative and to be implemented partnering with Eutelsat. In an official blog post CEO Mark Zuckerberg writes this is the first project under Internet.org […]
Read more ›
April 26, 2023 12:17 pm
Do you ever ask why Mondays and Fridays are the days you recollect the most while dull mid-week days convey less significance, making them all the more effortlessly mistook for each other? This is on account of Mondays for you signifies “exhausting”, “feverish” and “tired” and Fridays are connected with […]
Read more ›
April 25, 2023 2:16 am
John Nash, 86, is One among the genius mathematicians and a holder of Nobel in economics.His life motivated a book ‘A Beautiful Mind‘hit to win Oscar, sadly met his death in a car accident on Saturday night.Nash’s significant additions made ‘Game Theory’ on hot spot and are widely used in […]
Read more ›
1:35 am
Medtronic, a medical technology, services and solutions company, reported Thursday that its clinical trial for the Medtronic Evera MRI SureScan implantable cardioverter defibrillator (ICD) following magnetic resonance imaging (MRI) scans met its safety and efficacy endpoints. The Evera MRI Clinical Trial, a multi-center, prospective, controlled clinical trial, is the first […]
Read more ›
1:01 am
Shares of Bellicum Pharmaceuticals Inc. were near unchanged Thursday morning after the Texas-based biopharmaceutical firm reported that a recently-conducted clinical study to treat blood cancers showed positive results. The study evaluated immune reconstitution, safety and anti-viral response in patients undergoing T cell-depleted, haploidentical hematopoietic stem cell transplant (haplo-HSCT), followed by […]
Read more ›
12:45 am
Health Insurance Innovations shares dropped to trade just 4 cents above its 52-week low on Thursday after reporting disappointing Q1 earnings and sales. HIIQ was down 23% recently at $5.98, having earlier traded as low as $5.34. The 52-week range is between $5.30 and $14.24. The developer and administrator of […]
Read more ›